Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722

Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687

MODELS OF AMYLOID SEEDING IN ALZHEIMER'S DISEASE AND SCRAPIE: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins

Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507

Dissociation of somatostatin and parvalbumin interneurons circuit dysfunctions underlying hippocampal theta and gamma oscillations impaired by amyloid β oligomers in vivo

Chung, H., Park, K., Jang, H. J., Kohl, M. M., & Kwag, J. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02044-3 · Cited by 85

Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies

Eisele, Y. S., & Duyckaerts, C. J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1516-y · Cited by 82

Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition

Cabrera, E., Mathews, P. M., Mezhericher, E., Beach, T. G., Deng, J., Neubert, T. A., Rostagno, A. A., & Ghiso, J. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.005 · Cited by 78

Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid

Fritschi, S. K., Langer, F., Kaeser, S. A., Maia, L. F., Portelius, E., Pinotsi, D., Kaminski, C. F., Winkler, D. T., Maetzler, W., Keyvani, K., et al. (2014) · Brain · doi:10.1093/brain/awu255 · Cited by 83

Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates

Bae, E.-J., Yang, N. Y., Lee, C., Kim, S., Lee, H.-J., & Lee, S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.283 · Cited by 77

Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo

Sowade, R. F., & Jahn, T. R. (2017) · Nature Communications · doi:10.1038/s41467-017-00579-4 · Cited by 78

Prions and protein-folding diseases: Review: Prions and protein-folding diseases

Norrby, E. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02387.x · Cited by 75

Do Astrocytes Collaborate with Neurons in Spreading the “Infectious” Aβ and Tau Drivers of Alzheimer’s Disease?

Prà, I. D., Chiarini, A., Gui, L., Chakravarthy, B., Pacchiana, R., Gardenal, E., Whitfield, J. F., & Armato, U. (2014) · The Neuroscientist · doi:10.1177/1073858414529828 · Cited by 79

Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation

ElAli, A., Thériault, P., Préfontaine, P., & Rivest, S. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-75 · Cited by 72

Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains

Angarica, V. E., Ventura, S., & Sancho, J. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-316 · Cited by 74

Potential human transmission of amyloid β pathology: surveillance and risks

Lauwers, E., Lalli, G., Brandner, S., Collinge, J., Compernolle, V., Duyckaerts, C. J., Edgren, G., Haı̈k, S., Hardy, J., Helmy, A. E., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30238-6 · Cited by 74

Olfactory pathogenesis of idiopathic Parkinson disease revisited

Lerner, A., & Bagic, A. I. (2008) · Movement Disorders · doi:10.1002/mds.22066 · Cited by 73

FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism

Chen, X., Ji, B., Hao, X., Li, X., Eisele, F., Nyström, T., & Petranović, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14525-4 · Cited by 77

Prion-like seeding and nucleation of intracellular amyloid-β

Olsson, T. T., Klementieva, O. L., & Gouras, G. K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.015 · Cited by 74

Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases

Walker, L. C., & LeVine, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.399378 · Cited by 75

Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation

Ono, K., Takahashi, R., Ikeda, T., Mizuguchi, M., Hamaguchi, T., & Yamada, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.002 · Cited by 70

Distribution of Amyloid Precursor Protein and Amyloid-β in Ocular Hypertensive C57BL/6 Mouse Eyes

Kipfer-Kauer, A., McKinnon, S. J., Frueh, B. E., & Goldblum, D. (2010) · Current Eye Research · doi:10.3109/02713683.2010.494240 · Cited by 74

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?

Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70

Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease

Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 71

Prion-like activity of Cu/Zn superoxide dismutase

Grad, L. I., & Cashman, N. R. (2014) · Prion · doi:10.4161/pri.27602 · Cited by 69

Aβ seeds resist inactivation by formaldehyde

Fritschi, S. K., Cintron, A. F., Ye, L., Mahler, J., Bühler, A., Baumann, F., Neumann, M., Nilsson, K. P. R., Hammarström, P., Walker, L. C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1339-2 · Cited by 71

Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration

Scialò, C., Cecco, E. D., Manganotti, P., & Legname, G. (2019) · Viruses · doi:10.3390/v11030261 · Cited by 69

Cofactor Molecules Induce Structural Transformation during Infectious Prion Formation

Miller, M. B., Wang, D. W., Wang, F., Noble, G. P., Ma, J., Woods, V. L., Li, S., & Supattapone, S. (2013) · Structure · doi:10.1016/j.str.2013.08.025 · Cited by 68

Ceramides and sphingomyelinases in senile plaques

Panchal, M., Gaudin, M., Lazar, A. N., Salvati, E., Rivals, I., Ayciriex, S., Dauphinot, L., Dargère, D., Auzeil, N., Masserini, M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.010 · Cited by 69

Cofactors influence the biological properties of infectious recombinant prions

Fernández‐Borges, N., Bari, M. A. D., Eraña, H., Sánchez‐Martín, M., Pirisinu, L., Parra, B., Elezgarai, S. R., Vanni, I., López-Moreno, R., Vaccari, G., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1782-y · Cited by 70

Peptides as Potential Therapeutics for Alzheimer’s Disease

Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69

Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit

Guest, W. C., Silverman, J. M., Pokrishevsky, E., O’Neill, M. A., Grad, L. I., & Cashman, N. R. (2011) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2011.618967 · Cited by 67

Review: Contribution of transgenic models to understanding human prion disease

Wadsworth, J. D. F., Asante, E. A., & Collinge, J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01129.x · Cited by 65

Erratum: De novo induction of amyloid-β deposition in vivo

Morales, R., Duran-Aniotz, C. A., Castilla, J., Estrada, L. D., & Soto, C. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.153 · Cited by 67

Prion-like mechanisms in Alzheimer disease

Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 67

A novel and rapid method for obtaining high titre intact prion strains from mammalian brain

Wenborn, A., Terry, C., Gros, N., Joiner, S., D’Castro, L., Panico, S., Sells, J., Cronier, S., Linehan, J. M., Brandner, S., et al. (2015) · Scientific Reports · doi:10.1038/srep10062 · Cited by 67

Role of Apolipoprotein E in β-Amyloidogenesis

Hori, Y., Hashimoto, T., Nomoto, H., Hyman, B. T., & Iwatsubo, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.622209 · Cited by 69

The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease

Duyckaerts, C. J., Clavaguera, F., & Potier, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000672 · Cited by 71

Trans-synaptic degeneration in the visual pathway: Neural connectivity, pathophysiology, and clinical implications in neurodegenerative disorders

Sharma, S., Chitranshi, N., Wall, R. V., Basavarajappa, D. K., Gupta, V., Mirzaei, M., Graham, S. L., Klistorner, A. I., & You, Y. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.06.001 · Cited by 66

Alzheimer Aβ peptide interactions with lipid membranes

Tofoleanu, F., & Buchete, N. (2012) · Prion · doi:10.4161/pri.21022 · Cited by 66

Prion-like features of misfolded Aβ and tau aggregates

Morales, R., Callegari, K., & Soto, C. A. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.031 · Cited by 65

Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression

Ruiz‐Riquelme, A., Lau, H. H. C., Stuart, E., Goczi, A. N., Wang, Z., Schmitt‐Ulms, G., & Watts, J. C. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0529-x · Cited by 69

Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms

Masnata, M., Sciacca, G., Maxan, A., Bousset, L., Denis, H. L., Lauruol, F., David, L. S., Saint‐Pierre, M., Kordower, J. H., Melki, R., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01973-6 · Cited by 64

Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection

Brown, M. R., Radford, S. E., & Hewitt, E. W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.609073 · Cited by 67

Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery

Ji, Y., Chen, X., Wang, Z., Meek, C. J., McLean, J. L., Yang, Y., Yuan, C., Rochet, J., Liu, F., & Xu, R. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03041-w · Cited by 74

Aggregated proteins in schizophrenia and other chronic mental diseases

Korth, C. (2012) · Prion · doi:10.4161/pri.18989 · Cited by 64

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?

Beekes, M., Thomzig, A., Schulz‐Schaeffer, W., & Burger, R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1324-9 · Cited by 67

Prion strains in mammals: Different conformations leading to disease

Morales, R. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006323 · Cited by 64

Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease

Li, S., Jin, M., Liu, L., Dang, Y., Ostaszewski, B. L., & Selkoe, D. J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0626-x · Cited by 64

The Cause of Alzheimer’s Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress

Decourt, B., D’Souza, G. X., Shi, J., Ritter, A., Suazo, J., & Sabbagh, M. N. (2022) · Aging and disease · doi:10.14336/ad.2021.0529 · Cited by 69

APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?

Jordà‐Siquier, T., Petrel, M., Kouskoff, V., Smailovic, U., Cordelières, F., Frykman, S., Müller, U., Mulle, C., & Barthet, G. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12546 · Cited by 63

The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies

Goedert, M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.001 · Cited by 67

Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases

Walker, L. C. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034943 · Cited by 60

Glymphatic system dysfunction in neurodegenerative diseases

Beschörner, N., & Nedergaard, M. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001252 · Cited by 60

Cellular Aspects of Prion Replication In Vitro

Grassmann, A., Wolf, H., Hofmann, J. P., Graham, J. F., & Vorberg, I. M. (2013) · Viruses · doi:10.3390/v5010374 · Cited by 62

Unraveling prion strains with cell biology and organic chemistry

Aguzzi, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710824105 · Cited by 62

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Burwinkel, M., Lutzenberger, M., Heppner, F. L., Schulz‐Schaeffer, W., & Baier, M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0511-7 · Cited by 61

Cause and consequence of Aβ – Lipid interactions in Alzheimer disease pathogenesis

Rangachari, V., Dean, D. N., Rana, P., Vaidya, A., & Ghosh, P. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.004 · Cited by 61

From nucleation to widespread propagation: A prion-like concept for ALS

Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65

Ubiquitous Amyloids

Puławski, W., Ghoshdastider, U., Andrisano, V., & Filipek, S. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9549-3 · Cited by 60

Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases

Nussbaum-Krammer, C. I., & Morimoto, R. I. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013011 · Cited by 68

Neuritic Plaques — Gateways to Understanding Alzheimer’s Disease

Tsering, W., & Prokop, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03736-7 · Cited by 59

Persistence of Aβ seeds in APP null mouse brain

Ye, L., Fritschi, S. K., Schelle, J., Obermüller, U., Degenhardt, K., Kaeser, S. A., Eisele, Y. S., Walker, L. C., Baumann, F., Staufenbiel, M., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4117 · Cited by 58

Small molecule inhibitors of Abetaassembly

LeVine, H. (2007) · Amyloid · doi:10.1080/13506120701461020 · Cited by 58

Spreading of a Prion Domain from Cell-to-Cell by Vesicular Transport in Caenorhabditis elegans

Nussbaum-Krammer, C. I., Park, K.-W., Li, L., Melki, R., & Morimoto, R. I. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003351 · Cited by 58

In Vivo Turnover of Tau and APP Metabolites in the Brains of Wild-Type and Tg2576 Mice: Greater Stability of sAPP in the β-Amyloid Depositing Mice

Morales‐Corraliza, J., Mazzella, M. J., Berger, J. D., Diaz, N. S., Choi, J. H. K., Levy, E., Matsuoka, Y., Planel, E., & Mathews, P. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007134 · Cited by 60

Progression of Seed‐Induced A β Deposition within the Limbic Connectome

Ye, L., Hamaguchi, T., Fritschi, S. K., Eisele, Y. S., Obermüller, U., Jucker, M., & Walker, L. C. (2015) · Brain Pathology · doi:10.1111/bpa.12252 · Cited by 60

Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties

Tatarnikova, O. G., Орлов, М. А., & Bobkova, N. V. (2015) · Biochemistry (Moscow) · doi:10.1134/s000629791513012x · Cited by 62

Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?

Meyer‐Luehmann, M., & Prinz, M. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.011 · Cited by 58

The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer’s disease

Lau, H. H. C., Ingelsson, M., & Watts, J. C. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02201-2 · Cited by 57

Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U

Lee, E. B., Russ, J., Jung, H., Elman, L. B., Chahine, L. M., Kremens, D. E., Miller, B. L., Coslett, H. B., Trojanowski, J. Q., Deerlin, V. M. V., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-9 · Cited by 58

Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-β Precursor Protein Transgenic Mice

Jendresen, C., Hao, C., Zhang, X. L., Vlodavsky, I., Nilsson, L. N. G., & Li, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600569 · Cited by 59

Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach

Toni, M., Massimino, M. L., Mario, A. D., Angiulli, E., & Spisni, E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00003 · Cited by 56

Prion diseases: immunotargets and therapy

Panegyres, P. K., & Burchell, J. T. (2016) · ImmunoTargets and Therapy · doi:10.2147/itt.s64795 · Cited by 57

Mutant Presenilin 1 Increases the Expression and Activity of BACE1

Giliberto, L., Borghi, R., Piccini, A., Mangerini, R., Sorbi, S., Cirmena, G., Garuti, A., Ghetti, B. F., Tagliavini, F., Mughal, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805685200 · Cited by 56

Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease

Serrano‐Pozo, A., Mielke, M. L., Muzitansky, A., Gómez‐Isla, T., Growdon, J. H., Bacskai, B. J., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825e77de · Cited by 57

Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases

Jackson, W. S., Borkowski, A. W., Watson, N., King, O. D., Faas, H., Jasanoff, A., & Lindquist, S. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312006110 · Cited by 53

Protective effect of xanthohumol against age-related brain damage

Rancán, L., Paredes, S. D., García, I., Muñoz, P., Garcı́a, C., de Hontanar, G. L., la Fuente, M. D., Vara, E., & Tresguerres, J. A. F. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.011 · Cited by 59

Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin

Tan, Z., Dai, W., van Erp, T. G. M., Overman, J., Demuro, A., Digman, M. A., Hatami, A., Albay, R., Sontag, E. M., Potkin, K. T., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.81 · Cited by 57

Distinct Spacing Between Anionic Groups: An Essential Chemical Determinant for Achieving Thiophene‐Based Ligands to Distinguish β‐Amyloid or Tau Polymorphic Aggregates

Klingstedt, T., Shirani, H., Mahler, J., Wegenast‐Braun, B. M., Nyström, S., Goedert, M., Jucker, M., & Nilsson, K. P. R. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500556 · Cited by 58

Conversion of Synthetic Aβ toIn VivoActive Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model

Novotny, R., Langer, F., Mahler, J., Skodras, A., Vlachos, A., Wegenast‐Braun, B. M., Kaeser, S. A., Neher, J. J., Eisele, Y. S., Pietrowski, M. J., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0258-16.2016 · Cited by 55

Amyloid Beta Inhibits Olfactory Bulb Activity and the Ability to Smell

Alvarado-Martínez, R., Salgado-Puga, K., & Peña‐Ortega, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075745 · Cited by 54

Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts

Malchiodi‐Albedi, F., Paradisi, S., Matteucci, A., Frank, C., & Diociaiuti, M. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/906964 · Cited by 55

Conformational Transformation and Selection of Synthetic Prion Strains

Ghaemmaghami, S., Watts, J. C., Nguyen, H.-O. B., Hayashi, S., DeArmond, S. J., & Prusiner, S. B. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.07.021 · Cited by 53

Pathogenic Serum Amyloid A 1.1 Shows a Long Oligomer-rich Fibrillation Lag Phase Contrary to the Highly Amyloidogenic Non-pathogenic SAA2.2

Srinivasan, S., Patke, S., Wang, Y., Ye, Z., Litt, J., Srivastava, S. K., López, M. M., Kurouski, D., Lednev, I. K., Kane, R. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394155 · Cited by 54

Microparticles: A New Perspective in Central Nervous System Disorders

Schindler, S. M., Little, J. P., & Klegeris, A. (2014) · BioMed Research International · doi:10.1155/2014/756327 · Cited by 59

Molecular structure of an N-terminal phosphorylated β-amyloid fibril

Hu, Z., Vugmeyster, L., Au, D. F., Ostrovsky, D., Sun, Y. P., & Qiang, W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818530116 · Cited by 55

Molecular pathogenesis of sporadic prion diseases in man

Safar, J. (2012) · Prion · doi:10.4161/pri.18666 · Cited by 53

Phosphorylation of Ser8 promotes zinc-induced dimerization of the amyloid-β metal-binding domain

Kulikova, A. A., Tsvetkov, P. O., Indeykina, M. I., Popov, I. A., Zhokhov, S. S., Golovin, A. V., Polshakov, V. I., Kozin, S. A., Nudler, E., & Makarov, A. А. (2014) · Molecular BioSystems · doi:10.1039/c4mb00332b · Cited by 53

Emergence and natural selection of drug-resistant prions

Shorter, J. (2010) · Molecular BioSystems · doi:10.1039/c004550k · Cited by 55

An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials

Bousset, L., Brundin, P., Böckmann, A., Meier, B., & Melki, R. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150691 · Cited by 53

Age-Dependent Protein Aggregation Initiates Amyloid-β Aggregation

Groh, N., Bühler, A., Huang, C., Li, K. W., van Nierop, P., Smit, A. B., Fändrich, M., Baumann, F., & David, D. C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00138 · Cited by 53

Aβ seeding potency peaks in the early stages of cerebral β‐amyloidosis

Ye, L., Rasmussen, J., Kaeser, S. A., Marzesco, A., Obermüller, U., Mahler, J., Schelle, J., Odenthal, J., Krüger, C., Fritschi, S. K., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744067 · Cited by 54

Prion Diseases

Tee, B. L., Longoria-Ibarrola, E. M., & Geschwind, M. D. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.07.005 · Cited by 57

Molecular polymorphism of Aβ in Alzheimer's disease

LeVine, H., & Walker, L. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.026 · Cited by 54

Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease

Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51

How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders

Carlson, G. A., & Prusiner, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094861 · Cited by 51

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Wısnıewskı, T., & Boutajangout, A. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20156 · Cited by 53

Association between Deposition of Beta-Amyloid and Pathological Prion Protein in Sporadic Creutzfeldt-Jakob Disease

Debatin, L., Streffer, J. R., Geissen, M., Matschke, J., Aguzzi, A., & Glatzel, M. (2008) · Neurodegenerative Diseases · doi:10.1159/000121389 · Cited by 51

Towards authentic transgenic mouse models of heritable PrP prion diseases

Watts, J. C., Giles, K., Bourkas, M. E. C., Patel, S. S., Oehler, A., Gavidia, M., Bhardwaj, S., Lee, J., & Prusiner, S. B. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1585-6 · Cited by 49

Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients

Zhao, J., Rostgaard, K., Lauwers, E., Dahlén, T., Ostrowski, S. R., Erikstrup, C., Pedersen, O. B., Strooper, B. D., Lemmens, R., Hjalgrim, H., et al. (2023) · JAMA · doi:10.1001/jama.2023.14445 · Cited by 51

Oligomers of β-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model

Gaspar, R. C., Villarreal, S. A., Bowles, N. P., Hepler, R. W., Joyce, J. G., & Shughrue, P. J. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.001 · Cited by 53

Prions: Beyond a Single Protein

Das, A. S., & Zou, W. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-15 · Cited by 52

Prion‐like propagation as a pathogenic principle in frontotemporal dementia

Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 58

Phosphorylation of the Amyloid-Beta Peptide Inhibits Zinc-Dependent Aggregation, Prevents Na,K-ATPase Inhibition, and Reduces Cerebral Plaque Deposition

Barykin, E. P., Petrushanko, I. Y., Kozin, S. A., Telegin, G. B., Чернов, А. С., Lopina, O. D., Radko, S. P., Mitkevich, V. A., & Makarov, A. А. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00302 · Cited by 49

S5‐03–03: Induction of cerebral beta‐amyloidosis in transgenic mice

Jucker, M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.574

P1‐035: Exogenous induction of Abeta‐amyloidosis: Peripheral and stainless‐steel‐wire inoculations

Eisele, Y. S., Bolmont, T., Heikenwälder, M. F., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., & Jucker, M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.620

Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation

Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z. X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., et al. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-26933 · Cited by 4

Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903200106 · Cited by 279

Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats

Rosen, R. F., Fritz, J. J., Dooyema, J. M., Cintron, A. F., Hamaguchi, T., Lah, J. J., LeVine, H., Jucker, M., & Walker, L. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07551.x · Cited by 126